Loading…

Evaluation of the Frequency of Familial Hypercholesterolemia: A Single-Center Experience

Objective: Familial hypercholesterolemia is an autosomal dominant disease associated with elevated low-density lipoprotein cholesterol and increased premature atherosclerosis. In the general population, the frequency of familial hypercholesterolemia has been calculated to be between 1/500-1/200. Alt...

Full description

Saved in:
Bibliographic Details
Published in:Turkish journal of endocrinology and metabolism 2019, Vol.23 (3), p.168-173
Main Authors: EREN, Mehmet Ali, GÖNEL, Ataman, KOYUNCU, İsmail, GÖKAY, Ahmet Cebeli, SABUNCU, Tevfik
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Familial hypercholesterolemia is an autosomal dominant disease associated with elevated low-density lipoprotein cholesterol and increased premature atherosclerosis. In the general population, the frequency of familial hypercholesterolemia has been calculated to be between 1/500-1/200. Although the frequency of familial hypercholesterolemia belonging to different countries has been elaborately reported, the data from Turkey remains insufficient. We aimed to determine the frequency and characteristics of familial hypercholesterolemia in patients from Turkey by screening and analyzing the low-density lipoprotein cholesterol data. Material and Methods: Between May 2017-May 2018, 20151 laboratory records from individuals elaborately admitted to outpatient clinics for any reason were screened retrospectively, and 430 patients with low-density lipoprotein cholesterol levels ≥190 mg/dL were included in the study. Results:We observed a secondary cause (secondary hyperlipidemia, the SH group) in 163 patients and familial hypercholesterolemia in 267 patients (1.32%, the familial hypercholesterolemia group) in patients representing our population. The ratio of female to male participants was higher (76.4%vs. 58.4%) and their mean age was significantly higher in the SH group than in the familial hypercholesterolemia group (56.8±13.6 vs 47.1±17.0 years; both p
ISSN:1301-2193
1308-9846
DOI:10.25179/tjem.2019-65855